The NBA has completed an investigation involving infectious disease specialists and test manufacturers into the antibody test results of 2,300 players and staff for the season, citing further evidence of the need for booster-dose Covid-19 vaccines for league personnel, according to a copy of the statement. study findings obtained by ESPN.
The NBA study found that Moderna and Pfizer vaccines created higher levels of antibodies compared to Johnson and Johnson and detailed the decline in antibodies over time. The NBA wanted to understand the effectiveness of different vaccines and what different levels of antibodies might mean for the risk of infection.
The NBA is aware of 34 cases of fully vaccinated players or team personnel who became infected with a breakthrough case of Covid-19 through Nov. 19, including 31 with detectable levels of antibodies significantly lower than those seen in the remaining test population, according to the NBA. report. Three of the 34 infections happened with “undetected” antibody levels, the study said.
The NBA has a 97 percent vaccination rate among its players, the league says. The NBA is using the report’s findings to encourage eligible players to follow the NBA/NBPA’s previous recommendation to get a booster shot, and team doctors are expected to use these results to prep players. explain the importance of additional vaccination protection.
Of the 2,388 people tested in the preseason, 75 produced “undetected” results, 11 percent of whom had received the Johnson and Johnson vaccine. That percentage was significantly higher than those given Pfizer (1 percent) and Moderna (0.2 percent).
Those results suggest that those who received the J&J vaccine at least two months ago — or a second dose of Pfizer or Moderna at least six months ago — are at increased risk for breakthrough infections.